Difficulty: Medium
Average Score: 88%
Practice
Which of the following drugs is preferred for termination of paroxysmal supraventricular tachycardia
Correct answer
D
Rationale
In the context of drugs affecting the cardiovascular system, the correct answer for the termination of paroxysmal supraventricular tachycardia is Verapamil (Option D). Verapamil is a calcium channel blocker that acts on the AV node to slow conduction, making it effective in terminating re-entrant supraventricular tachycardias like paroxysmal supraventricular tachycardia (PSVT).
Digoxin (Option A) is primarily used for heart failure and atrial fibrillation but is not the drug of choice for terminating PSVT. Quinidine (Option B) is a class I antiarrhythmic agent that can be proarrhythmic and is not commonly used for PSVT termination. Propranolol (Option C) is a beta-blocker that can slow heart rate but is not as effective as Verapamil in terminating PSVT due to its mechanism of action.
In an educational context, understanding the mechanism of action of different drugs is crucial in selecting the most appropriate treatment for specific cardiovascular conditions. Verapamil's specific action on the AV node and its efficacy in terminating PSVT make it the preferred choice in this scenario, highlighting the importance of drug selection based on mechanism of action and desired outcomes in clinical practice.
Digoxin (Option A) is primarily used for heart failure and atrial fibrillation but is not the drug of choice for terminating PSVT. Quinidine (Option B) is a class I antiarrhythmic agent that can be proarrhythmic and is not commonly used for PSVT termination. Propranolol (Option C) is a beta-blocker that can slow heart rate but is not as effective as Verapamil in terminating PSVT due to its mechanism of action.
In an educational context, understanding the mechanism of action of different drugs is crucial in selecting the most appropriate treatment for specific cardiovascular conditions. Verapamil's specific action on the AV node and its efficacy in terminating PSVT make it the preferred choice in this scenario, highlighting the importance of drug selection based on mechanism of action and desired outcomes in clinical practice.